查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1861928

PET-CT掃描儀市場按應用、設備類型、最終用戶、服務類型和機架類型分類－2025-2032年全球預測

PET-CT Scanners Market by Application, Device Type, End User, Service Type, Gantry Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，PET-CT 掃描儀市場將成長至 42.7 億美元，複合年成長率為 5.31%。

關鍵市場統計數據
基準年 2024 28.2億美元
預計年份：2025年 29.7億美元
預測年份 2032 42.7億美元
複合年成長率 (%) 5.31%

在醫療保健系統中，對PET-CT成像的臨床相關性、技術發展以及採購和服務提供影響進行策略性分析。

正子斷層掃描-電腦斷層掃描（PET-CT）已發展成為功能診斷和解剖診斷的交會點，成為一種重要的影像學技術。它能夠同時顯示代謝活動和形態細節，為腫瘤學、心臟病學和神經病學等重要臨床路徑提供支持，同時也為研究和治療診斷應用提供了支持。除了臨床價值之外，PET-CT系統還在重塑醫院、診斷中心和研究機構的工作流程、資本投資計畫和服務模式。

檢測器材料、影像重建演算法和整合軟體平台的技術進步提高了影像保真度、掃描速度和定量精度。這些進步，以及人們對新型放射性示蹤劑和混合診斷治療通訊協定日益成長的興趣，正在重新定義診斷效率和患者吞吐量的預期。因此，相關人員必須應對更為複雜的採購環境，在這個環境中，設備性能、示蹤劑生態系統和服務合約相互作用，共同決定臨床和經濟效益。

在此背景下，策略決策需要從整體觀點，涵蓋設備架構、機架性能、維護和升級路徑以及最終用戶的操作需求。後續章節將整合並說明影響技術採納的變革性變化、貿易政策阻力、市場區隔差異、區域趨勢、競爭要務以及領導者可採取的實際步驟。其目標是提供一個系統性的視角，以支持在臨床、財務和監管領域做出明智的選擇。

檢測器創新、人工智慧驅動的軟體、不斷發展的示蹤劑生態系統以及新的部署模式正在共同重塑臨床工作流程、採購和服務策略。

PET-CT系統格局正經歷多重整合的變革，這些變革正在重塑臨床工作流程、供應鏈和商業化策略。檢測器靈敏度和重建技術的快速發展，使得掃描時間得以縮短，病灶檢出更加精準，從而顯著提升了工作流程效率和診斷信心。同時，軟體主導的進步（尤其是人工智慧和定量成像技術）正在提升整合平台的價值，這些平台能夠提供決策支援、自動化品管和簡化的報告流程。

在營運方面，醫療服務提供者正在評估新的部署模式，力求平衡固定安裝與行動/分散式服務，以擴大服務覆蓋範圍，惠及服務不足的地區，並最佳化掃描器的運轉率。服務合約、遠距離診斷和預防性保養計劃的日益普及進一步強化了這一轉型，旨在確保設備運作並延長使用壽命。同時，示蹤生態系統也不斷多元化。雖然傳統的放射性示蹤劑仍是核心，但對非FDG示蹤劑和治療-診斷組合的探索正在加速，這促使設備製造商、放射性藥物供應商和臨床團隊之間進行更緊密的合作。

最後，監管要求和報銷框架也在不斷發展，以應對品質保證、資料管治和基於價值的醫療服務。這些變化促使供應商和醫療機構優先考慮互操作系統、完善的文件記錄和以結果為導向的證據產生。總而言之，這些變革性的變化提升了整合技術服務夥伴關係關係和策略規劃在PET-CT能力取得、實施和維護方面的作用。

評估近期關稅調整如何改變了診斷影像設備及關鍵零件的採購經濟效益、供應鏈韌性和籌資策略。

主要經濟體關稅調整的累積影響正在產生一系列營運和策略效應，相關人員應認真考慮這些效應。診斷影像設備及組件進口關稅的提高通常會導致最終用戶到岸成本上升，迫使採購團隊重新評估總擁有成本 (TCO) 並探索替代籌資策略。由於關稅導致部分供應路線不再經濟，製造商和供應商可能會考慮加快本地化生產、實現採購來源多元化或重新配置組件採購，以降低貿易壁壘的影響。

除了直接的成本影響外，關稅變化還可能導致現有供應鏈出現摩擦，並延長關鍵備件和替換模組的前置作業時間。這項風險凸顯了服務彈性和庫存規劃對於依賴快速取得零件以維持臨床連續性的醫療服務提供者的重要性。此外，監管合規和海關程序也會增加跨境交易的行政負擔，影響合約條款、保固結構和服務等級協議的談判。

為此，相關人員正在重新評估其籌資策略，優先考慮便於本地組裝和維修的模組化設計，並加強與本地分銷商和服務供應商的合作。同時，他們優先選擇對進口依賴性較低的設備，並利用資金籌措機制來減輕資本支出的影響。總而言之，這些調整顯示貿易政策的變化如何影響整個生態系統，進而影響資本投資決策、服務可靠性以及新技術的採用速度。

基於細分市場的洞察，將臨床應用、設備類型、最終用戶需求、服務模式和機架配置與策略決策連結起來

對產品和服務細分的深入理解對於將技術產品與臨床應用案例和醫療機構能力相匹配至關重要。就臨床應用而言，心臟科、神經病學和腫瘤學各自有著獨特的需求。腫瘤學領域尤其活躍，其差異體現在兩種不同的示蹤劑選擇：一種是基於FDG的影像技術，能夠進行廣泛的代謝評估；另一種是非FDG示蹤劑，則針對特定的生物路徑和受體譜。這些應用層面的差異會影響掃描器的選擇標準、示蹤劑的物流以及影像通訊協定的設計。

設備類型的考量進一步完善了實施決策。固定系統通常適用於高運作的醫療機構，這些機構優先考慮容量和全面的功能，而行動單元則為小型機構的推廣計畫和共用服務安排提供了靈活性。最終用戶的多樣性也至關重要。診斷中心優先考慮容量和預約的便捷性，而醫院則需要在住院和門診病人工作流程之間取得平衡，並且可能需要整合電子健康記錄 (EHR) 連接。研究機構重視模組化和高階定量功能。在醫院環境中，私立醫療機構往往優先考慮客戶體驗和附加價值服務協議，而公立醫院則專注於成本效益和廣泛的覆蓋範圍。

服務模式的選擇——包括安裝、維護和升級——決定了設備的長期性能和生命週期成本。預防性維護和系統化的升級規劃有助於延長設備的使用壽命並保持影像品質。同時，安裝品質會影響初始校準和法規遵循。機架配置（多切面與單切片）會影響空間解析度、掃描時間和與先進重建技術的兼容性。整合這些分割鏡頭為產品藍圖和服務模式與市場需求的匹配奠定了全面的基礎。

美洲、歐洲、中東和非洲以及亞太地區的區域特徵將影響不同醫療保健系統的採購趨勢、服務模式和追蹤物流。

區域趨勢導致需求模式和營運考量各異，進而影響相關人員的投資和實施重點。在美洲，醫療系統呈現出多種多樣的支付模式和融資方式，大型三級醫療機構往往是先進影像技術的早期採用者。因此，整合的工作流程、強大的服務網路以及與多種放射性示踪劑的兼容性對於支持複雜的腫瘤學、神經病學和心臟影像影像項目至關重要。

歐洲、中東和非洲地區法規環境和採購模式的多樣性要求企業採取靈活的商業策略。在一些市場，公共醫療系統優先考慮成本效益高的解決方案和長期維護契約，而私人醫療機構則在差異化服務和快速取得方面競爭。在迴旋加速器產能有限的市場，跨境合作和區域經銷夥伴是應對物流挑戰和確保示蹤劑供應持續性的常用方法。

亞太地區正經歷著裝機容量和技術應用的快速成長，同時也擁有成熟的卓越中心。大都會圈人口密度高，催生了可擴展解決方案的需求，包括行動部署以擴展服務覆蓋範圍至周邊地區。此外，在地化生產計劃以及全球供應商與區域合作夥伴之間的策略聯盟，正在影響產品本地化、監管申報時間表和售後服務模式。了解這些區域差異對於使產品和服務部署與當地營運實際情況相符至關重要。

競爭優勢正轉向結合硬體效能、軟體智慧、卓越服務和策略追蹤器夥伴關係的平台。

競爭格局日益受到硬體創新、軟體生態系統和服務品質三者交互作用的影響。領先的供應商正在尋求將平台功能與可擴展的軟體解決方案相結合的策略，以實現定量成像、工作流程自動化和遠距離診斷。與放射性藥物供應商和研究機構的合作正成為差異化價值提案的核心，從而能夠提供客製化的示蹤劑支持計畫和臨床證據，進而增強診斷定位。

服務和售後產品已成為收入成長和差異化的關鍵促進因素。延長保固期、基於績效的服務合約和遠端監控功能旨在減少停機時間，並為服務提供者帶來可預測的生命週期經濟效益。同時，模組化硬體架構和升級路徑使供應商能夠在不更換整個系統的情況下，透過提供漸進式改進來維護與現有客戶的關係。

從合資企業到區域生產和分銷協議，各種合作商業化模式正在幫助供應商應對目標市場的關稅風險和監管複雜性。同時，一些公司正在投資臨床團隊的培訓和認證項目，以支援先進的通訊協定和新型示踪劑，從而加速臨床應用。這些策略舉措預示著一個新時代的到來：將卓越技術與深厚的服務、對監管的深刻理解以及臨床合作相結合的解決方案，將決定競爭優勢。

為製造商、供應商和經銷商提供切實可行的優先建議，以增強供應韌性、提升服務價值並加速PET-CT技術的臨床應用。

為了兼顧臨床影響和商業性價值，產業領導者應採取切實可行的優先行動方案，在短期應對能力和長期策略定位之間取得平衡。首先，應實現供應鏈多元化，並評估區域組裝和本地夥伴關係的機會，以降低貿易政策波動帶來的風險，並縮短關鍵備件的前置作業時間。這種務實的做法將增強服務的連續性，並在不同的支付方環境下提供靈活的採購方式。

其次，需要投資軟體和分析能力，以增強影像量化、工作流程自動化和遠端服務診斷。這些能力不僅能提高診斷的一致性，還能透過服務訂閱和平台貨幣化創造持續價值。第三，透過預防性保養計畫、延長保固期和基於績效的服務協議來擴展服務範圍，使供應商的獎勵與臨床運轉率和影像品質掛鉤。

第四，我們將推動示蹤劑和研究合作，拓展臨床應用範圍，超越傳統藥物，並支持治療診斷學計畫和特殊影像需求。第五，我們將開發符合當地實際情況的商業模式，提供模組化融資、行動部署方案和培訓項目，以提升本地臨床能力。最後，我們將積極與監管機構和支付方溝通，使實證醫學方案與報銷預期和品質框架保持一致，確保順利實施並實現持續的臨床療效。

本報告所依據的研究綜合採用了一種透明的混合方法研究方法，結合了初步訪談、技術審查、監管分析和交叉檢驗，以確保提供可靠的實用見解。

本報告的研究綜合基於混合方法，強調對主要研究結果、技術文獻和監管文件進行三角驗證。主要研究包括對臨床負責人、影像物理學家、服務經理和採購專業人員進行結構化訪談，以了解不同醫療機構在營運方面面臨的挑戰、技術優先事項和決策標準。這些定性研究結果輔以設備層面的技術評估、同行評審的出版物和公開的監管文件，以檢驗性能特徵和合規途徑。

輔助證據收集包括分析臨床試驗註冊庫、審查示蹤劑開發平臺以及查閱會議論文，以了解新興應用和技術趨勢。在適用情況下，我們使用匿名案例研究和營運審核結果來評估安裝實務、維護結構和服務模式的有效性。在整個過程中，我們採用專家交叉檢驗來確保準確性並發現不同的觀點。

透過敏感性分析和方法論保障措施，識別並解決了研究限制。數據品管包括資訊來源檢驗、同儕審查決策以及對推斷性結論的清晰審核追蹤。調查方法強調透明度和可重複性，使客戶對研究結果的可靠性和情境相關性充滿信心，從而支持其策略決策。

一項綜合性研究，將技術進步、服務模式和政策趨勢連結起來，從而得出最佳化PET-CT應用、臨床價值和韌性的策略要務。

本執行摘要提供的綜合分析表明，PET-CT 仍然是一項重要的診斷和研究工具，其策略價值因近期技術和組織變革而得到提升。檢測器技術、重建演算法和軟體驅動工作流程的創新正在提高診斷和營運效率，而不斷發展的示蹤劑格局和混合臨床模式正在拓展該技術的臨床應用範圍。同時，貿易政策的波動以及採購、監管和基礎設施的區域差異，也帶來了獨特的營運挑戰和策略機會。

對於相關人員，至關重要的是要進行觀點思考，協調產品設計與服務交付，建立能夠降低外部衝擊風險的供應鏈，並投資於能夠創造持久價值的軟體和臨床夥伴關係。這將使製造商、供應商和經銷商能夠確保PET-CT技術既能改善患者預後，又能實現可預測的營運績效。本報告的洞見和建議旨在為資本配置、產品藍圖和合作策略提供參考，從而塑造PET-CT技術應用和臨床整合的下一階段。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 將人工智慧和深度學習演算法整合到PET-CT成像工作流程中，以提高癌症患者的診斷準確性
  • 開發和商業化一種全身PET-CT系統，該系統能夠以高靈敏度和短掃描時間提供動態全身成像。
  • PET-CT是一種用於免疫PET應用的新型放射性追蹤劑，能夠即時監測癌症免疫治療反應。
  • 攜帶式、小型設備的出現使得照護現場分子成像成為可能，即使在農村地區和醫療資源有限的機構也是如此。
  • 透過對現有PET-CT系統進行改造，加裝矽光電倍增器檢測器，以提高空間解析度和定量精度。
  • 監管部門的核准和報銷政策的變化正在加速亞太和拉丁美洲醫療保健市場對 PET-CT 的採用。
  • 與影像診斷中心和放射性藥物生產商合作，開發用於治療診斷應用的個人化PET-CT通訊協定
  • 利用創新示蹤劑拓展PET-CT的臨床應用：從腫瘤學到神經學和心血管疾病診斷
  • 將PET-CT數據與先進的放射組學和精準醫學平台結合，用於癌症治療計劃的預測分析。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 PET-CT掃描儀市場依應用領域分類

  • 心臟病學
  • 神經病學
  • 腫瘤學
    • FDG示踪劑
    • 非FDG示踪劑

9. PET-CT掃描儀市場（依設備類型分類）

  • 固定的
  • 移動的

第10章 PET-CT掃描儀市場（按最終用戶分類）

  • 診斷中心
  • 醫院
    • 私立醫院
    • 公立醫院
  • 研究所

第11章 依服務類型分類的PET-CT掃描儀市場

  • 安裝
  • 維護
  • 升級

第12章 PET-CT掃描儀市場（依機架類型分類）

  • 多切面
  • 單切片

第13章 PET-CT掃描儀市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 PET-CT掃描儀市場（按類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國PET-CT掃描儀市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • General Electric Company
    • Siemens Healthineers AG
    • Koninklijke Philips NV
    • Canon Medical Systems Corporation
    • United Imaging Healthcare Co., Ltd.
    • Neusoft Corporation
    • Hitachi, Ltd.
    • Shimadzu Corporation
    • Analogic Corporation
    • Fujifilm Holdings Corporation
Product Code: MRR-521BAA36EA75

The PET-CT Scanners Market is projected to grow by USD 4.27 billion at a CAGR of 5.31% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.82 billion
Estimated Year [2025] USD 2.97 billion
Forecast Year [2032] USD 4.27 billion
CAGR (%) 5.31%

A strategic orientation to PET-CT imaging that frames its clinical relevance, technological evolution, and implications for procurement and service delivery within healthcare systems

Positron emission tomography-computed tomography (PET-CT) has evolved into a cornerstone imaging modality, uniquely positioned at the intersection of functional and anatomical diagnostics. Its capacity to visualize metabolic activity alongside morphological detail underpins crucial clinical pathways across oncology, cardiology, and neurology, while supporting research and theranostic applications. Beyond clinical value, PET-CT systems shape workflows, capital planning, and service models for hospitals, diagnostic centers, and research institutions.

Technological progress in detector materials, image reconstruction algorithms, and integrated software platforms has enhanced image fidelity, scan speed, and quantitative accuracy. These advances, together with growing interest in novel radiotracers and hybrid diagnostic-therapeutic protocols, have redefined expectations for diagnostic yield and patient throughput. As a result, stakeholders must navigate a more complex procurement landscape where device capabilities, tracer ecosystems, and service commitments converge to influence clinical and economic outcomes.

In this context, strategic decision-making requires a holistic view that encompasses device architecture, gantry performance, service and upgrade pathways, and end-user operational needs. The subsequent sections synthesize transformative shifts affecting technology adoption, trade-policy headwinds, segmentation nuances, regional dynamics, competitive imperatives, and actionable steps for leaders. The aim is to provide a structured narrative that supports informed choices across clinical, financial, and regulatory domains.

How detector innovation, AI-enabled software, evolving tracer ecosystems, and new deployment models are jointly reshaping clinical workflows, procurement, and service strategies

The landscape for PET-CT systems is undergoing several convergent shifts that are transforming clinical workflows, supply chains, and commercialization strategies. Rapid improvements in detector sensitivity and reconstruction techniques are enabling shorter scan times and finer lesion detectability, yielding tangible workflow efficiencies and diagnostic confidence. Concurrently, software-driven advancements-particularly in artificial intelligence and quantitative imaging-are increasing the value of integrated platforms that offer decision support, automated quality control, and streamlined reporting.

On the operational front, healthcare providers are evaluating new deployment models that balance fixed installations with mobile or decentralized services to reach underserved populations and optimize scanner utilization. This transition is reinforced by a growing emphasis on service contracts, remote diagnostics, and preventive maintenance programs that preserve uptime and extend asset life. At the same time, the tracer ecosystem is diversifying: while established radiotracers remain central, research into non-FDG agents and theranostic pairs is accelerating, prompting closer collaboration between device manufacturers, radiopharmaceutical suppliers, and clinical teams.

Finally, regulatory expectations and reimbursement frameworks are evolving to address quality assurance, data governance, and value-based care. These changes are encouraging vendors and providers to prioritize interoperable systems, robust documentation, and outcomes-oriented evidence generation. Taken together, these transformative shifts are elevating the role of integrated technology-service partnerships and strategic planning in shaping how PET-CT capabilities are acquired, deployed, and sustained.

Assessing how recent tariff adjustments have altered sourcing economics, supply chain resilience, and procurement strategies for imaging hardware and critical components

The cumulative impact of tariff changes imposed by a major economy has created a set of operational and strategic effects that stakeholders must weigh carefully. Increased import duties on imaging hardware and components typically result in higher landed costs for end users, prompting procurement teams to reassess total cost of ownership considerations and to explore alternative sourcing strategies. As tariffs render some supply routes less economical, manufacturers and suppliers may accelerate localization of manufacturing, diversify sourcing footprints, or reconfigure component sourcing to mitigate exposure to trade barriers.

Beyond immediate cost implications, tariff-driven shifts can introduce friction into existing supply chains, generating longer lead times for critical spare parts and replacement modules. This risk underscores the importance of service resilience and inventory planning for providers that rely on rapid access to components to maintain clinical continuity. Moreover, regulatory compliance and customs procedures can add administrative burden to cross-border transactions, influencing contract terms, warranty structures, and the negotiation of service-level agreements.

In response, stakeholders tend to recalibrate procurement strategies, increase emphasis on modular designs that facilitate local assembly or repair, and strengthen partnerships with regional distributors and service providers. Concurrently, there is a tendency to prioritize devices with lower import intensity or to leverage financing mechanisms that smooth capital expenditure impacts. Taken together, these adaptations demonstrate how trade policy shocks propagate across the ecosystem, affecting capital decisions, service reliability, and the pace at which new technologies are adopted.

Segmentation-driven insights that connect clinical applications, device typologies, end-user requirements, service modalities, and gantry architectures to strategic decision-making

A nuanced understanding of product and service segmentation is essential to align technology offerings with clinical use cases and institutional capabilities. In terms of clinical application, cardiology, neurology, and oncology represent distinct demand drivers; oncology remains particularly dynamic, with differentiation between FDG-based imaging that supports broad metabolic assessment and non-FDG tracers that target specific biological pathways or receptor profiles. These application-level distinctions influence scanner selection criteria, tracer logistics, and the design of imaging protocols.

Device type considerations further refine deployment decisions. Fixed systems typically serve high-volume centers where throughput and comprehensive functionality are priorities, while mobile units provide flexibility for outreach programs and shared-service arrangements among smaller institutions. End-user diversity matters as well: diagnostic centers prioritize throughput and ease of scheduling, hospitals balance inpatient and outpatient workflows and may require integrated electronic health record connectivity, and research institutes value modularity and advanced quantitative capabilities. Within hospital settings, private facilities often emphasize customer experience and value-added service agreements, whereas public hospitals focus on cost-effectiveness and broad access.

Service type choices-installation, maintenance, and upgrades-determine long-term performance and lifecycle economics. Proactive maintenance regimes and structured upgrade paths can extend useful life and preserve image quality, while installation quality affects initial calibration and regulatory compliance. Gantry architecture, whether multi-slice or single-slice, has implications for spatial resolution, scan time, and compatibility with advanced reconstruction techniques. Integrating these segmentation lenses yields a comprehensive foundation for matching product roadmaps and service models to market needs.

Regional nuances across the Americas, Europe-Middle East-Africa, and Asia-Pacific that shape procurement preferences, service models, and tracer logistics across diverse healthcare systems

Regional dynamics create varied demand characteristics and operational considerations that influence how stakeholders prioritize investment and deployment. In the Americas, healthcare systems display a wide spectrum of payer models and capital financing approaches, and large tertiary centers often act as early adopters of advanced imaging modalities. As a result, emphasis is placed on integrated workflows, robust service networks, and compatibility with a range of radiotracers to support complex oncologic, neurologic, and cardiac imaging programs.

The Europe, Middle East & Africa region encompasses diverse regulatory environments and procurement modalities, driving a need for adaptable commercial strategies. In several markets, publicly funded health systems prioritize cost-effective solutions and long-term maintenance agreements, while private centers compete on service differentiation and rapid access. Cross-border collaboration and regional distribution partnerships are common approaches to address logistical challenges and to ensure continuity of tracer supply in markets with limited cyclotron infrastructure.

Asia-Pacific presents a broad mix of rapidly expanding capacity and technology adoption alongside mature centers of excellence. High population density in large metropolitan areas creates demand for scalable solutions, including mobile deployments to extend access to peripheral regions. Additionally, local manufacturing initiatives and strategic alliances between global vendors and regional partners are influencing product localization, regulatory submission timelines, and aftermarket service models. Understanding these regional nuances is essential for aligning product offerings and service footprints with on-the-ground operational realities.

How competitive advantage is shifting toward integrated platforms that combine hardware performance, software intelligence, service excellence, and strategic tracer partnerships

Competitive dynamics are increasingly defined by the interplay between hardware innovation, software ecosystems, and service excellence. Leading suppliers pursue strategies that combine platform performance with scalable software solutions that enable quantitative imaging, workflow automation, and remote diagnostics. Partnerships with radiopharmaceutical suppliers and research institutions are becoming central to differentiated value propositions, enabling tailored tracer-support programs and clinical evidence generation that reinforce diagnostic positioning.

Service and aftermarket offerings represent a growing revenue and differentiation vector. Extended warranties, performance-based service contracts, and remote-monitoring capabilities are being positioned to reduce downtime and provide predictable lifecycle economics for providers. At the same time, modular hardware architectures and upgrade pathways help vendors preserve installed-base relationships while offering incremental feature improvements without complete system replacement.

Collaborative commercialization models-ranging from joint ventures to localized manufacturing and distribution agreements-help vendors address tariff exposures and regulatory complexities in target markets. In parallel, some companies are investing in training and accreditation programs for clinical teams to support advanced protocols and novel tracers, thereby accelerating clinical adoption. Together, these strategic moves indicate that competitive advantage increasingly hinges on integrated solutions that combine technical excellence with service depth, regulatory insight, and clinical partnership.

Practical, prioritized recommendations for manufacturers, providers, and distributors to strengthen supply resilience, expand service value, and accelerate clinical adoption of PET-CT technologies

To capture both clinical impact and commercial value, industry leaders should adopt a set of pragmatic, prioritized actions that balance near-term resilience with long-term positioning. First, diversify supply chains and evaluate opportunities for regional assembly or local partnerships to reduce exposure to trade-policy disruptions and to shorten lead times for critical spares. This pragmatic approach will strengthen service continuity and provide procurement flexibility across different payer environments.

Second, invest in software and analytics capabilities that enhance image quantitation, workflow automation, and remote service diagnostics. These capabilities not only improve diagnostic consistency but also create recurring value through service subscriptions and platform monetization. Third, expand service footprints through preventive maintenance programs, extended warranties, and outcome-oriented service contracts that align vendor incentives with clinical uptime and image quality.

Fourth, pursue tracer and research collaborations to broaden clinical applications beyond conventional agents, supporting theranostic programs and specialty imaging needs. Fifth, tailor commercial models to regional realities by offering modular financing, mobile deployment options, and training programs that build local clinical capacity. Finally, engage proactively with regulators and payers to align evidence generation plans with reimbursement expectations and quality frameworks, ensuring smoother adoption pathways and sustained clinical impact.

A transparent, mixed-methods research approach that blends primary interviews, technical reviews, regulatory analysis, and cross-validation to ensure robust, actionable insights

The research synthesis underpinning this report is grounded in a mixed-methods approach that emphasizes triangulation of primary insights, technical literature, and regulatory documentation. Primary research included structured interviews with clinical leaders, imaging physicists, service managers, and procurement specialists to elicit operational challenges, technology priorities, and decision criteria across diverse care settings. These qualitative inputs were complemented by device-level technical reviews, peer-reviewed publications, and public regulatory filings to validate performance attributes and compliance pathways.

Secondary evidence streams involved analysis of clinical trial registries, tracer development pipelines, and conference proceedings to capture emerging applications and technology directions. Where applicable, anonymized case studies and operational audits informed assessments of installation practices, maintenance regimes, and service model efficacy. Throughout the process, findings were cross-validated with subject-matter experts to ensure accuracy and to surface divergent perspectives.

Limitations were acknowledged and addressed through sensitivity checks and methodological safeguards. Data quality controls included source verification, reviewer adjudication, and a clear audit trail for inferential claims. The methodology emphasizes transparency and reproducibility, providing clients with confidence in the reliability of the insights and the contextual relevance for strategic decision-making.

Concluding synthesis that links technological advances, service models, and policy dynamics to strategic imperatives for optimizing PET-CT deployment, clinical value, and resilience

The synthesis presented throughout this executive summary underscores that PET-CT remains a critical diagnostic and research tool whose strategic value is amplified by recent technological and organizational shifts. Innovations in detector technology, reconstruction algorithms, and software-driven workflow enhancements are increasing diagnostic yield and operational efficiency, while evolving tracer landscapes and hybrid clinical paradigms expand the modality's clinical footprint. At the same time, trade-policy perturbations and regional nuances in procurement, regulation, and infrastructure create differentiated operational challenges and strategic opportunities.

For stakeholders, the imperative is to think holistically: align product design with service offerings, build supply chains that reduce exposure to external shocks, and invest in software and clinical partnerships that generate sustained value. By doing so, manufacturers, providers, and distributors can ensure that PET-CT capabilities deliver both improved patient outcomes and predictable operational performance. The insights and recommendations in this report are intended to inform capital allocation, product roadmaps, and collaborative strategies that will shape the next phase of PET-CT adoption and clinical integration.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of artificial intelligence and deep learning algorithms into PET-CT imaging workflows to enhance diagnostic accuracy in oncology patients
  • 5.2. Development and commercialization of total-body PET-CT systems offering whole-body dynamic imaging with high sensitivity and reduced scan times
  • 5.3. Adoption of novel radiotracers in PET-CT for immunoPET applications to monitor cancer immunotherapy response in real time
  • 5.4. Emergence of portable and compact PET-CT scanners enabling point-of-care molecular imaging in rural and underserved healthcare facilities
  • 5.5. Retrofitting existing PET-CT systems with silicon photomultiplier detectors to improve spatial resolution and quantitative accuracy
  • 5.6. Regulatory approvals and reimbursement policy changes accelerating PET-CT adoption in Asia Pacific and Latin American healthcare markets
  • 5.7. Collaborations between imaging centers and radiopharmaceutical companies to develop personalized PET-CT protocols for theranostic applications
  • 5.8. Expansion of PET-CT clinical applications beyond oncology into neurology and cardiovascular disease diagnostics through innovative tracers
  • 5.9. Integration of PET-CT data with advanced radiomics and precision medicine platforms for predictive analytics in cancer treatment planning

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. PET-CT Scanners Market, by Application

  • 8.1. Cardiology
  • 8.2. Neurology
  • 8.3. Oncology
    • 8.3.1. FDG Tracer
    • 8.3.2. Non-FDG Tracer

9. PET-CT Scanners Market, by Device Type

  • 9.1. Fixed
  • 9.2. Mobile

10. PET-CT Scanners Market, by End User

  • 10.1. Diagnostic Centers
  • 10.2. Hospitals
    • 10.2.1. Private Hospitals
    • 10.2.2. Public Hospitals
  • 10.3. Research Institutes

11. PET-CT Scanners Market, by Service Type

  • 11.1. Installation
  • 11.2. Maintenance
  • 11.3. Upgrades

12. PET-CT Scanners Market, by Gantry Type

  • 12.1. Multi-Slice
  • 12.2. Single-Slice

13. PET-CT Scanners Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. PET-CT Scanners Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. PET-CT Scanners Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. General Electric Company
    • 16.3.2. Siemens Healthineers AG
    • 16.3.3. Koninklijke Philips N.V.
    • 16.3.4. Canon Medical Systems Corporation
    • 16.3.5. United Imaging Healthcare Co., Ltd.
    • 16.3.6. Neusoft Corporation
    • 16.3.7. Hitachi, Ltd.
    • 16.3.8. Shimadzu Corporation
    • 16.3.9. Analogic Corporation
    • 16.3.10. Fujifilm Holdings Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL PET-CT SCANNERS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PET-CT SCANNERS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL PET-CT SCANNERS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PET-CT SCANNERS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS PET-CT SCANNERS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL PET-CT SCANNERS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. PET-CT SCANNERS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. PET-CT SCANNERS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. PET-CT SCANNERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL PET-CT SCANNERS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL PET-CT SCANNERS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL PET-CT SCANNERS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL PET-CT SCANNERS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL PET-CT SCANNERS MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL PET-CT SCANNERS MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL PET-CT SCANNERS MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL PET-CT SCANNERS MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL PET-CT SCANNERS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL PET-CT SCANNERS MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL PET-CT SCANNERS MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL PET-CT SCANNERS MARKET SIZE, BY NEUROLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL PET-CT SCANNERS MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL PET-CT SCANNERS MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL PET-CT SCANNERS MARKET SIZE, BY FDG TRACER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL PET-CT SCANNERS MARKET SIZE, BY FDG TRACER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL PET-CT SCANNERS MARKET SIZE, BY FDG TRACER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL PET-CT SCANNERS MARKET SIZE, BY FDG TRACER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL PET-CT SCANNERS MARKET SIZE, BY FDG TRACER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL PET-CT SCANNERS MARKET SIZE, BY FDG TRACER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL PET-CT SCANNERS MARKET SIZE, BY NON-FDG TRACER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL PET-CT SCANNERS MARKET SIZE, BY NON-FDG TRACER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL PET-CT SCANNERS MARKET SIZE, BY NON-FDG TRACER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL PET-CT SCANNERS MARKET SIZE, BY NON-FDG TRACER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL PET-CT SCANNERS MARKET SIZE, BY NON-FDG TRACER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL PET-CT SCANNERS MARKET SIZE, BY NON-FDG TRACER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL PET-CT SCANNERS MARKET SIZE, BY FIXED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL PET-CT SCANNERS MARKET SIZE, BY FIXED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL PET-CT SCANNERS MARKET SIZE, BY FIXED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL PET-CT SCANNERS MARKET SIZE, BY FIXED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL PET-CT SCANNERS MARKET SIZE, BY FIXED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL PET-CT SCANNERS MARKET SIZE, BY FIXED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MOBILE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MOBILE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MOBILE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MOBILE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MOBILE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MOBILE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL PET-CT SCANNERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL PET-CT SCANNERS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL PET-CT SCANNERS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL PET-CT SCANNERS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL PET-CT SCANNERS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL PET-CT SCANNERS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL PET-CT SCANNERS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL PET-CT SCANNERS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL PET-CT SCANNERS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL PET-CT SCANNERS MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL PET-CT SCANNERS MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL PET-CT SCANNERS MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL PET-CT SCANNERS MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL PET-CT SCANNERS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL PET-CT SCANNERS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL PET-CT SCANNERS MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL PET-CT SCANNERS MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL PET-CT SCANNERS MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL PET-CT SCANNERS MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL PET-CT SCANNERS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL PET-CT SCANNERS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL PET-CT SCANNERS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL PET-CT SCANNERS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL PET-CT SCANNERS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL PET-CT SCANNERS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL PET-CT SCANNERS MARKET SIZE, BY INSTALLATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL PET-CT SCANNERS MARKET SIZE, BY INSTALLATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL PET-CT SCANNERS MARKET SIZE, BY INSTALLATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL PET-CT SCANNERS MARKET SIZE, BY INSTALLATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL PET-CT SCANNERS MARKET SIZE, BY INSTALLATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL PET-CT SCANNERS MARKET SIZE, BY INSTALLATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MAINTENANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MAINTENANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MAINTENANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MAINTENANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MAINTENANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MAINTENANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL PET-CT SCANNERS MARKET SIZE, BY UPGRADES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL PET-CT SCANNERS MARKET SIZE, BY UPGRADES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL PET-CT SCANNERS MARKET SIZE, BY UPGRADES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL PET-CT SCANNERS MARKET SIZE, BY UPGRADES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL PET-CT SCANNERS MARKET SIZE, BY UPGRADES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL PET-CT SCANNERS MARKET SIZE, BY UPGRADES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MULTI-SLICE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MULTI-SLICE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MULTI-SLICE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MULTI-SLICE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MULTI-SLICE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MULTI-SLICE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL PET-CT SCANNERS MARKET SIZE, BY SINGLE-SLICE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL PET-CT SCANNERS MARKET SIZE, BY SINGLE-SLICE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL PET-CT SCANNERS MARKET SIZE, BY SINGLE-SLICE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL PET-CT SCANNERS MARKET SIZE, BY SINGLE-SLICE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL PET-CT SCANNERS MARKET SIZE, BY SINGLE-SLICE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL PET-CT SCANNERS MARKET SIZE, BY SINGLE-SLICE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL PET-CT SCANNERS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL PET-CT SCANNERS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. AMERICAS PET-CT SCANNERS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 124. AMERICAS PET-CT SCANNERS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 125. AMERICAS PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 126. AMERICAS PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 127. AMERICAS PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 129. AMERICAS PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 130. AMERICAS PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 131. AMERICAS PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 132. AMERICAS PET-CT SCANNERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 133. AMERICAS PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 134. AMERICAS PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 135. AMERICAS PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 137. AMERICAS PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2025-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 142. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 144. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 146. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 148. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 150. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 152. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2025-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 158. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 160. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 162. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 164. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 166. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 168. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2025-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPE PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE PET-CT SCANNERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 208. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 212. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 214. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. AFRICA PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. AFRICA PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. AFRICA PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 222. AFRICA PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 223. AFRICA PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 224. AFRICA PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 225. AFRICA PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. AFRICA PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. AFRICA PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 228. AFRICA PET-CT SCANNERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 229. AFRICA PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 230. AFRICA PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 231. AFRICA PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. AFRICA PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. AFRICA PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. AFRICA PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL PET-CT SCANNERS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL PET-CT SCANNERS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 253. ASEAN PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. ASEAN PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. ASEAN PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 256. ASEAN PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 257. ASEAN PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 258. ASEAN PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 259. ASEAN PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. ASEAN PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. ASEAN PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. ASEAN PET-CT SCANNERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. ASEAN PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 264. ASEAN PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 265. ASEAN PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. ASEAN PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. ASEAN PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. ASEAN PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. GCC PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. GCC PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. GCC PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 272. GCC PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 273. GCC PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 274. GCC PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 275. GCC PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. GCC PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 277. GCC PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 278. GCC PET-CT SCANNERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 279. GCC PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 280. GCC PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 281. GCC PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. GCC PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 283. GCC PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. GCC PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2025-2032 (USD MILLION)
  • TABLE 301. BRICS PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 302. BRICS PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 303. BRICS PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 304. BRICS PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 305. BRICS PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 306. BRICS PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 307. BRICS PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 308. BRICS PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 309. BRICS PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 310. BRICS PET-CT SCANNERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 311. BRICS PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 312. BRICS PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 313. BRICS PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 314. BRICS PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 315. BRICS PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. BRICS PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. G7 PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 318. G7 PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 319. G7 PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 320. G7 PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 321. G7 PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 322. G7 PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 323. G7 PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 324. G7 PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 325. G7 PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 326. G7 PET-CT SCANNERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 327. G7 PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 328. G7 PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 329. G7 PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 330. G7 PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 331. G7 PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2024 (USD MILLION)
  • TABLE 332. G7 PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2025-2032 (USD MILLION)
  • TABLE 333. NATO PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 334. NATO PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 335. NATO PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 336. NATO PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 337. NATO PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 338. NATO PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 339. NATO PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 340. NATO PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 341. NATO PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 342. NATO PET-CT SCANNERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 343. NATO PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 344. NATO PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 345. NATO PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 346. NATO PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 347. NATO PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2024 (USD MILLION)
  • TABLE 348. NATO PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2025-2032 (USD MILLION)
  • TABLE 349. GLOBAL PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 350. GLOBAL PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 351. UNITED STATES PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 352. UNITED STATES PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 353. UNITED STATES PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 354. UNITED STATES PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 355. UNITED STATES PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 356. UNITED STATES PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 357. UNITED STATES PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 358. UNITED STATES PET-CT SCANNERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 359. UNITED STATES PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 360. UNITED STATES PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 361. UNITED STATES PET